CONTINULIN Trademark

Trademark Overview


On Wednesday, August 24, 2011, a trademark application was filed for CONTINULIN with the United States Patent and Trademark Office. The USPTO has given the CONTINULIN trademark a serial number of 85406120. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 8, 2013. This trademark is owned by Eli Lilly and Company. The CONTINULIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis and treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antipsychotic pharma...
continulin

General Information


Serial Number85406120
Word MarkCONTINULIN
Filing DateWednesday, August 24, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 8, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 10, 2012

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis and treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antipsychotic pharmaceutical preparations; antidepressants

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 29, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, April 8, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 8, 2013ABANDONMENT - NO USE STATEMENT FILED
Saturday, July 21, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 19, 2012EXTENSION 1 GRANTED
Thursday, July 19, 2012EXTENSION 1 FILED
Thursday, July 19, 2012TEAS EXTENSION RECEIVED
Tuesday, March 6, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 10, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 10, 2012PUBLISHED FOR OPPOSITION
Wednesday, December 21, 2011NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 5, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 1, 2011ASSIGNED TO EXAMINER
Monday, August 29, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, August 27, 2011NEW APPLICATION ENTERED IN TRAM